Dipyaman Modak

Dipyaman Modak

Auto-generated profile, based on publicly available information

Dipyaman Modak

Gense Technologies Ltd., Hong Kong, China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 November 2022 in Scientific Reports
Verified
Journal Article
Open access
PDF file
FZFedi Zouari
Fedi Zouari
WOWei Yi Oon
Wei Yi Oon
DMDipyaman Modak
Dipyaman Modak
WLWing Hang Lee
Wing Hang Lee
WANG CHUN KWOKWANG CHUN KWOK
WANG CHUN KWOK
RCRussell W. Chan
Russell W. Chan
Accessibility of diagnostic screening and treatment monitoring devices for respiratory diseases is critical in promoting healthcare and reducing sudden complications and mortality. Spirometry is the standard for diagnosing and monitoring several lung diseases. However, it lacks regional assessment capabilities necessary for detecting subtle regional changes in certain diseases. It also requires challenging breathing maneuvers difficult for elderlies, children, and diseased patients. Here, we actualized an affordable, portable, and self-administrable electrical impedance tomography (EIT) system for home-based lung function assessment and telemedicine. Through simultaneous EIT-spirometry trials on healthy subjects, we demonstrated that our device can predict spirometry indicators over a wide range and can provide regional mapping of these indicators. We further developed a close-to-effortless breathing paradigm and tested it by longitudinally monitoring a COVID-19 discharged subject and two healthy controls with results suggesting the paradigm can detect initial deterioration followed by recovery. Overall, the EIT system can be widely applicable for lung function screening and monitoring both at homes and clinics.